X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (98668) 98668
Newsletter (12273) 12273
Newspaper Article (2759) 2759
Book Chapter (541) 541
Dissertation (447) 447
Magazine Article (397) 397
Transcript (190) 190
Publication (131) 131
Book / eBook (95) 95
Conference Proceeding (81) 81
Government Document (41) 41
Web Resource (38) 38
Reference (35) 35
Trade Publication Article (33) 33
Book Review (11) 11
Journal / eJournal (8) 8
Paper (7) 7
Report (2) 2
Streaming Video (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47748) 47748
proteases (35633) 35633
animals (30554) 30554
protease inhibitors (30051) 30051
biochemistry & molecular biology (18374) 18374
male (17397) 17397
female (15093) 15093
research (14037) 14037
protease inhibitors - pharmacology (12005) 12005
proteins (11491) 11491
protease (10421) 10421
adult (9458) 9458
hiv infections - drug therapy (9374) 9374
mice (9242) 9242
analysis (9142) 9142
hiv (8664) 8664
pharmacology & pharmacy (8459) 8459
amino acid sequence (8321) 8321
expression (7796) 7796
molecular sequence data (7776) 7776
immunology (7719) 7719
middle aged (7512) 7512
cell biology (7293) 7293
infectious diseases (7202) 7202
apoptosis (7108) 7108
rats (7036) 7036
enzymes (6608) 6608
health aspects (6032) 6032
microbiology (5950) 5950
kinetics (5649) 5649
physiological aspects (5563) 5563
protease inhibitor (5282) 5282
virology (5128) 5128
inhibitors (5074) 5074
antiviral agents (4835) 4835
cancer (4835) 4835
activation (4798) 4798
peptides (4797) 4797
chemistry, medicinal (4792) 4792
models, molecular (4724) 4724
hiv protease inhibitors - therapeutic use (4640) 4640
aids (4567) 4567
research article (4475) 4475
universities and colleges (4451) 4451
mutation (4425) 4425
proteolysis (4405) 4405
cells, cultured (4112) 4112
substrate specificity (4098) 4098
oncology (4093) 4093
drug therapy (4090) 4090
gene expression (4078) 4078
purification (4029) 4029
binding sites (4023) 4023
drug therapy, combination (3959) 3959
protein binding (3948) 3948
identification (3932) 3932
cell line (3909) 3909
multidisciplinary sciences (3837) 3837
structure-activity relationship (3802) 3802
anti-hiv agents - therapeutic use (3767) 3767
genetic aspects (3763) 3763
biochemistry (3732) 3732
cells (3699) 3699
care and treatment (3638) 3638
aged (3620) 3620
biophysics (3573) 3573
in-vitro (3516) 3516
protease inhibitors - therapeutic use (3383) 3383
antiretroviral therapy (3356) 3356
inhibitor (3320) 3320
medical research (3275) 3275
life sciences (3257) 3257
chemistry, organic (3239) 3239
hydrogen-ion concentration (3195) 3195
hiv infections - virology (3194) 3194
time factors (3178) 3178
infection (3144) 3144
inflammation (3100) 3100
hiv-1 - drug effects (3088) 3088
medicine (3055) 3055
protease inhibitors - chemistry (3036) 3036
biotechnology & applied microbiology (3034) 3034
thrombin (2981) 2981
molecular weight (2966) 2966
viral load (2935) 2935
binding (2902) 2902
cysteine (2902) 2902
hiv protease inhibitors - pharmacology (2891) 2891
crystal-structure (2885) 2885
peptide hydrolases - metabolism (2826) 2826
hepatitis c virus (2792) 2792
human immunodeficiency virus--hiv (2790) 2790
biology (2782) 2782
treatment outcome (2771) 2771
dose-response relationship, drug (2766) 2766
protein conformation (2759) 2759
therapy (2739) 2739
cell line, tumor (2721) 2721
inhibition (2711) 2711
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (65) 65
Online Resources - Online (32) 32
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Chemistry (A D Allen) - Stacks (4) 4
Chemistry (A D Allen) - May be requested in 6-10 wks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Robarts - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (112341) 112341
Japanese (1386) 1386
Russian (782) 782
German (636) 636
French (593) 593
Spanish (478) 478
Chinese (198) 198
Portuguese (198) 198
Polish (105) 105
Italian (81) 81
Czech (49) 49
Korean (48) 48
Hungarian (35) 35
Dutch (21) 21
Ukrainian (21) 21
Danish (15) 15
Swedish (12) 12
Slovak (9) 9
Turkish (7) 7
Bulgarian (6) 6
Norwegian (6) 6
Hebrew (5) 5
Romanian (5) 5
Croatian (3) 3
Finnish (3) 3
Indonesian (3) 3
Persian (3) 3
Serbian (3) 3
Slovenian (3) 3
Arabic (2) 2
Catalan (2) 2
Lithuanian (2) 2
Afrikaans (1) 1
Breton (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of neurochemistry, ISSN 0022-3042, 2012, Volume 120, Issue 1, pp. 71 - 83
Journal Article
Biochimica et biophysica acta. Biomembranes, ISSN 0005-2736, 2013, Volume 1828, Issue 12, pp. 2898 - 2907
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2012, Volume 156, Issue 4, pp. 279 - 290
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2007, Volume 21, Issue 4, pp. 517 - 533
.... Several DPP-4 inhibitors are in clinical development. Most experience so far has been with sitagliptin (Merck... 
Endocrinology & Metabolism | treatment | dipeptidyl peptidase 4 | sitagliptin | type-2 diabetes | vildagliptin | glucagon-like peptide-1 | GLYCEMIC CONTROL | DIPEPTIDYL-PEPTIDASE-IV | INSULIN-SECRETION | IMPROVED GLUCOSE-TOLERANCE | BETA-CELL FUNCTION | METFORMIN-TREATED PATIENTS | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | PLASMA-GLUCOSE | 7-36 AMIDE | Triazoles - adverse effects | Metformin - therapeutic use | Humans | Body Weight - drug effects | Pyrrolidines - adverse effects | Substrate Specificity | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Thiazolidinediones - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Protease Inhibitors - therapeutic use | Insulin Secretion | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Pioglitazone | Insulin - metabolism | Animals | Dipeptidyl-Peptidase IV Inhibitors | Lipid Metabolism - drug effects | Pyrazines - adverse effects | Glucagon - metabolism | Vildagliptin | Glucagon-Like Peptide 1 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Insulin - therapeutic use | Nitriles - therapeutic use | Clinical Medicine | Other Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Adamantane/adverse effects Adamantane/analogs & derivatives Adamantane/therapeutic use Animals Antigens | Annan klinisk medicin | Combination Glucagon/secretion Glucagon-Like Peptide 1/antagonists & inhibitors Glucagon-Like Peptide 1/physiology Humans Hypoglycemia/chemically induced Hypoglycemic Agents/therapeutic use Insulin/secretion Insulin/therapeutic use Lipid Metabolism/drug effects Metformin/therapeutic use Nitriles/adverse effects Nitriles/therapeutic use Protease Inhibitors/therapeutic use Pyrazines/adverse effects Pyrazines/therapeutic use Pyrrolidines/adverse effects Pyrrolidines/therapeutic use Substrate Specificity Thiazolidinediones/therapeutic use Triazoles/adverse effects Triazoles/therapeutic use | Type 2/drug therapy Drug Therapy | Klinisk medicin | CD26/antagonists & inhibitors Body Weight/drug effects Diabetes Mellitus
Journal Article
Cold Spring Harbor perspectives in biology, ISSN 1943-0264, 2013, Volume 5, Issue 8, pp. a008680 - a008680
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2017, Volume 140, Issue 8, pp. 1713 - 1726
Journal Article
Nature (London), ISSN 1476-4687, 2016, Volume 530, Issue 7589, pp. 233 - 236
.... In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle(2-5... 
VISUALIZATION | FALCIPARUM MALARIA | MECHANISM | SPECIFICITY | ARTEMISININ RESISTANCE | MULTIDISCIPLINARY SCIENCES | VALIDATION | ELECTRON-MICROSCOPY | IDENTIFICATION | PARASITE | HUMAN 20S PROTEASOME | Plasmodium falciparum - enzymology | Plasmodium - enzymology | Plasmodium chabaudi - enzymology | Species Specificity | Humans | Proteasome Inhibitors - chemistry | Plasmodium - drug effects | Plasmodium falciparum - drug effects | Protein Subunits - metabolism | Dose-Response Relationship, Drug | Artemisinins - pharmacology | Plasmodium chabaudi - physiology | Drug Design | Plasmodium - growth & development | Female | Drug Resistance | Antimalarials - adverse effects | Catalytic Domain | Proteasome Inhibitors - pharmacology | Models, Molecular | Proteasome Endopeptidase Complex - chemistry | Proteasome Inhibitors - toxicity | Proteasome Inhibitors - adverse effects | Antimalarials - pharmacology | Cryoelectron Microscopy | Drug Synergism | Animals | Substrate Specificity - drug effects | Proteasome Endopeptidase Complex - ultrastructure | Antimalarials - chemistry | Plasmodium chabaudi - drug effects | Mice | Mice, Inbred BALB C | Protein Subunits - antagonists & inhibitors | Protein Subunits - chemistry | Antimalarials - toxicity | Enzyme Activation | Plasmodium falciparum - growth & development | Proteasome Endopeptidase Complex - metabolism | Ubiquitin-proteasome system | Plasmodium | Health aspects | Proteins | Malaria | Protease inhibitors | Proteases | Erythrocytes | Ligands | Parasites | Drug dosages
Journal Article